CIMA LABS INC
10-Q, EX-27.1, 2000-11-13
PHARMACEUTICAL PREPARATIONS
Previous: CIMA LABS INC, 10-Q, EX-10.26, 2000-11-13
Next: CIMA LABS INC, 10-Q, EX-99.1, 2000-11-13



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from the
accompanying balance sheets of CIMA LABS, INC. as of September 30, 2000, and
the related statements of operations for the year ended September 30, 2000 and
is qualified in its entirety by reference to such financial statements.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                       7,888,503
<SECURITIES>                                 4,372,998
<RECEIVABLES>                                6,347,953
<ALLOWANCES>                                    25,000
<INVENTORY>                                  1,587,898
<CURRENT-ASSETS>                            20,373,567
<PP&E>                                      21,661,943
<DEPRECIATION>                               7,162,705
<TOTAL-ASSETS>                              35,214,995
<CURRENT-LIABILITIES>                        2,341,076
<BONDS>                                              0
                                0
                                          0
<COMMON>                                       109,538
<OTHER-SE>                                  77,874,422
<TOTAL-LIABILITY-AND-EQUITY>                35,214,995
<SALES>                                      9,291,430
<TOTAL-REVENUES>                            16,832,819
<CGS>                                        9,417,960
<TOTAL-COSTS>                                6,329,850
<OTHER-EXPENSES>                                22,824
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                           (502,906)
<INCOME-PRETAX>                              1,565,091
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                          1,565,091
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                    (799,337)
<NET-INCOME>                                   765,754
<EPS-BASIC>                                        .07
<EPS-DILUTED>                                      .07


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission